Dr. Ann-Lii Cheng Wins 2020 Blue Faery Award

AA

A A

Dr. Ann-Lii Cheng Wins 2020 Blue Faery Award

Dr. Ann-Lii Cheng Wins 2020 Blue Faery Award for Excellence in Liver Cancer Research

Professor Ann-Lii Cheng has contributed significantly to the basic knowledge and clinical application of molecular targeted therapy and immunotherapy in hepatocellular carcinoma (HCC). Living in the part of the world plagued by HCC, Prof. Cheng has devoted his career to substantiating a solution. Since 2004, he has been involved in the development of sorafenib and lenvatinib, two pivotal drugs in the first-line treatment of HCC, and recently the discovery of a new regimen, atezolizumab plus bevacizumab, which is considered an epoch-making breakthrough in this field. His research team at National Taiwan University has been recognized as one of the most prominent translational research groups in exploring the frontier of HCC treatment.

 

Dr. Jinsil Seong Wins 2019 Blue Faery Award

Jinsil Seong

Dr. Jinsil Seong Wins 2019 Blue Faery Award for Excellence in Liver Cancer Research

Professor Seong is one of a few who pioneered radiotherapy of Hepatocellular Carcinoma. She has devoted her entire career on radiotherapy of HCC by practicing, educating and pursuing clinical research. With her enthusiasm and devotion overcoming a minority issue not only in specialty (radiation oncology) but also in gender (women), she has served as a president of the Korean Liver Cancer Association. Additionally, she is the president-elect of the Asia Pacific Primary Liver cancer Expert (APPLE) association, which is a world leading liver cancer association.

Read Press Release.

Scroll Up